HC-X30

N/A

Report date: 2023/12/08 10:39:33
NME

Base Information

Drug NameHC-X30
Drug Alias NameHC-X30HCX30
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFocal adhesion kinase inhibitors
TargetsFocal adhesion kinase
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHinova Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHinova Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A